BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37385965)

  • 21. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway.
    Wu HE; Su CC; Wang SC; Liu PL; Cheng WC; Yeh HC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Chen YR; Yu YH; Huang SP; Li CY
    Am J Chin Med; 2023; 51(4):1019-1039. PubMed ID: 37120705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
    Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z
    Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells.
    Xu Y; Zheng J; Ye ZY
    Neoplasma; 2022 Sep; 69(5):1119-1128. PubMed ID: 36004650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway.
    Zhu S; Jiao W; Xu Y; Hou L; Li H; Shao J; Zhang X; Wang R; Kong D
    Life Sci; 2021 Dec; 286():120046. PubMed ID: 34653428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ProstaCaid induces G2/M cell cycle arrest and apoptosis in human and mouse androgen-dependent and-independent prostate cancer cells.
    Yan J; Katz AE
    Integr Cancer Ther; 2010 Jun; 9(2):186-96. PubMed ID: 20587444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.
    Kumar R; Srinivasan S; Koduru S; Pahari P; Rohr J; Kyprianou N; Damodaran C
    Cancer Prev Res (Phila); 2009 Mar; 2(3):234-43. PubMed ID: 19223576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
    Bonaccorsi L; Marchiani S; Muratori M; Forti G; Baldi E
    J Cancer Res Clin Oncol; 2004 Oct; 130(10):604-14. PubMed ID: 15258753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.
    Eroğlu C; Seçme M; Bağcı G; Dodurga Y
    Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
    MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
    Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo.
    Hu Z; Kong F; Si M; Tian K; Yu LX; Young CY; Yuan H; Lou H
    PLoS One; 2013; 8(9):e74387. PubMed ID: 24069304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
    Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
    Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
    Roberto D; Klotz LH; Venkateswaran V
    Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carvacrol Induced Program Cell Death and Cell Cycle Arrest in Androgen-Independent Human Prostate Cancer Cells
    Khan F; Singh VK; Saeed M; Kausar MA; Ansari IA
    Anticancer Agents Med Chem; 2019; 19(13):1588-1608. PubMed ID: 31364516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.